Clinical Trials Browser

Phase 2 × Small Cell Lung Carcinoma × cabazitaxel × Clear all

NCT01500720 2015-04-13

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Phase 2 Completed

179 enrolled 16 charts

Small Cell Lung Carcinoma